SEP 13 - 14 2017 Opens: 6:00 AM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Microbiology & Immunology 2017
12 52 4222

Welcome to the LabRoots Microbiology & Immunology 2017 Virtual Conference! Join us in bringing the Microbiology research community together online in discovering new concepts, tools and techniques to apply to ongoing research and diagnostics. This conference is free to attend.

Microbiology and Immunology cover an immense scope, encompassing various industries and research areas including pharmaceuticals, medicine, agriculture, and space. The development of new techniques and the ability to sequence organisms without the need to grow them in the laboratory has opened up a new world of microbial diversity and complexity we know little about. Being able to explore this biodiversity and use new knowledge for drug discovery and biotechnology applications is an exciting and expanding area of research.

With progress made toward learning more about the world of microbiology and disease, the need for more rapid diagnosis, increased standardization of testing and greater adaptability to manage threats from newly evolved infectious microorganisms will become more and more apparent. The combination of the new tools being developed along with advancements in basic knowledge can lead to profound changes and growth in Microbiology and Immunology.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

Topics for this years virtual conference include:

  • Virology
  • Antimicrobial
  • Food Microbiology
  • Beneficial Microbes
  • Polymicrobial
  • Microbiology of the Household Environment

Continuing Education

By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (PACE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

 Use #LRmicro to follow the conversation

  • Henry Ford II Professor and Departmental Chair of Ecology and Evolutionary Biology, Microbiology Faculty, Yale School of Medicine
  • Associate Professor, Laboratory Medicine and Medicine / Infectious Diseases Director, UCSF-Abbott Viral Diagnostics and Discovery Center Associate Director, UCSF Clinical Microbiology Laborat
  • Postdoctoral Research Scholar , Washington University School of Medicine
  • Science Communications Manager, Innovative Genomics Institute
  • Associate Professor, Molecular Microbiology and Immunology, Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health
  • Associate Professor , North Carolina State University
  • Professor Emeritus, West Virginia University School of Medicine
  • Professor of Biochemistry, John Coniglio Chair in Biochemistry, Vanderbilt University School of Medicine
  • SVP Medical Affairs, CEMPRA Inc

Show Resources
All times are Pacific Time


Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.


Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email

LabRoots Policy


  • Paul Turner, PhD
    Henry Ford II Professor and Departmental Chair of Ecology and Evolutionary Biology, Microbiology Faculty, Yale School of Medicine
      Paul Turner is the Elihu Professor of Ecology and Evolutionary Biology at Yale University, where he has served as Interim Dean of Science and Departmental Chair. He is also a faculty member in Microbiology at Yale University School of Medicine. Dr. Turner's research interests include: evolutionary biology, evolutionary medicine, infectious disease, microbiology, phage therapy, RNA viruses, vector-borne disease, and virology. He uses an interdisciplinary approach in his research laboratory, employing techniques from microbiology, population genetics, genomics, molecular biology and mathematical modeling to study hypotheses in ecology and evolutionary biology. Paul Turner received his Ph.D. from the Center for Microbial Ecology at Michigan State University. He then conducted postdoctoral work at University of Maryland College Park, University of Valencia in Spain, and the National Institutes of Health. He regularly serves on committees for the National Science Foundation, National Institutes of Health and the American Society for Microbiology. He was elected chair of international meetings, such as the 2013 Gordon Research Conference on Microbial Population Biology, and the 2018 Jacques Monod Conference on Viral Emergence. He has authored nearly 100 scholarly journal articles, reviews and book chapters.
    • Charles Chiu, MD, PhD
      Associate Professor, Laboratory Medicine and Medicine / Infectious Diseases Director, UCSF-Abbott Viral Diagnostics and Discovery Center Associate Director, UCSF Clinical Microbiology Laborat
        Dr. Charles Chiu, M.D./Ph.D., is an Assistant Professor in Laboratory Medicine and Medicine, Infectious Diseases at the University of California, San Francisco. He is also the Director of UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC) at China Basin and Associate Director of the UCSF Clinical Microbiology Laboratory. Charles is an expert in the emerging field of viral metagenomics, and his research is focused on the development of microarray and deep sequencing technologies for viral pathogen discovery and clinical diagnostics. He is also the principal investigator on an R01 grant from the NIH on blood bank pathogen screening, California Discovery, UC-MEXUS, and National Research Fund for Tickborne Diseases (NRFTD) grants on the microbial epidemiology of encephalitis, diarrhea, and Lyme disease, a QB3 Rogers Family Foundation Award in translational diagnostics, and a UCSF-Abbott Viral Discovery Award. Charles has more than 30 patents and peer-reviewed publications in scientific journals and ongoing collaborations with research groups and public health agencies worldwide, including Abbott Diagnostics, Inc., Global Viral Forecasting, the United States CDC, the American Red Cross, and the Texas Biomedical Research Institute.
      • Nathan Crook
        Postdoctoral Research Scholar , Washington University School of Medicine
          Nathan Crook is a postdoctoral researcher in the Department of Pathology & Immunology at Washington University School of Medicine in the laboratory of Prof. Gautam Dantas, where he is applying functional metagenomics and next-generation sequencing to improve control over colonization and gene expression in probiotic bacteria. Nathan received his B.S. in Chemical Engineering from the California Institute of Technology in 2009, and his PhD in Chemical Engineering from the University of Texas at Austin in 2014. During his graduate work in the Alper Lab, Nathan developed several high-throughput computational and experimental methods which accelerate the engineering of new industrial phenotypes in S. cerevisiae. In the future, Nathan aims to engineer probiotics for in situ synthesis and delivery of therapeutics. Nathan has published 10 papers relating to his work, in addition to 2 book chapters and 3 review articles. He has mentored 2 high school students, 6 undergraduates, and 4 graduate students in experimental synthetic biology research. Nathan received the National Science Foundation's Graduate Research Fellowship in 2010.
        • Megan Hochstrasser, PhD
          Science Communications Manager, Innovative Genomics Institute
            Megan has a B.A. in Biology from Brown University and received her Ph.D. from Jennifer Doudna's lab at UC Berkeley in 2016, where she studied mechanisms of CRISPR immunity in bacteria. She joined the IGI in September 2016 to handle scientific communications, hoping to bridge the gap between researchers and the public.
          • Sabra Klein, PhD
            Associate Professor, Molecular Microbiology and Immunology, Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health
          • Dorith Rotenberg
            Associate Professor , North Carolina State University
          • John Thomas, PhD
            Professor Emeritus, West Virginia University School of Medicine
              Professor Emeritus John G. Thomas, PhD, is recognized as an "International Educator and Global Microbiologist " ( having lectured in more than 43 countries while a clinical microbiologist in pathology (Professor), dentistry (Clinical Professor) and Graduate School Education (Adjunct Professor) for 54 years , his research emphasizing biofilms and medical devices. He has recently focused upon micro 3-D- bio Printing of contour fitting gauzes using bio-plastics and unique Prebiotics with Therapeutic Bacteria (Beneficial Bacteria) for chronic wound intervention (SMarT Gauze); this integrates a common pathway, visualized through his 'Microbial Clock' and recently created Center of Hologenomic Clinical Studies ( Center) which underscores a "Dual Citizenship" and co evolution of symbiotic microbes and human ecosystems. "Microbes Matter". His Probiotic Solutions integrates Computer Decision Support for Probiotic (Beneficial Bacteria) Guidelines combining AI, Artificial Intelligence and Precision Medicine, expanded recently to emphasize Chronic Wound Care and Aging, hypothesized now as a disease. He has over 50 publications, multiple book chapters and significant grant support. His military obligation (1969-71)(wounds) and his sabbatical at Cardiff University, Wales, UK (2007)(oral health, biofilms) have remained a driving catalyst. He has been a member of the American Dental Association Scientific Advisory Committee for the last 8 years and American Society of Microbiology for 54 years. As Faculty at 3 national (Northeastern Ohio Universities College of Medicine, Rutgers University and West Virginia University) and 2 international Universities ( National University of Singapore and Cardiff University) during his career , he has received multiple Alumni and University awards for research and Student Mentoring ; retiring from West Virginia University in 2013 after 23 years as Professor Emeritus , he presently is expanding his research/teaching utilizing the advanced resources of the Allegheny Health Network (Center of Excellence in Biofilm Research) and Carnegie -Mellon University, Pittsburg, PA, and Mass. Gen. Hospital (Dept. of Anesthesia and Critical Care) with Harvard University, Boston, MA, all under the umbrella of his Global Microbiology Consulting. (GMC) (
            • Neil Osheroff, PhD
              Professor of Biochemistry, John Coniglio Chair in Biochemistry, Vanderbilt University School of Medicine
                Neil Osheroff received a Bachelor's Degree in Chemistry from Hobart College in 1974 followed by a Ph.D. in Biochemistry and Molecular Biology from Northwestern University in 1979. His doctoral dissertation on the mechanism of action of cytochrome c was under the direction of Professor Emanuel Margoliash. Following his doctoral studies, Dr. Osheroff moved to the Stanford University School of Medicine in 1980, where he was a Helen Hay Whitney Foundation postdoctoral fellow with Dr. Douglas Brutlag in the Department of Biochemistry. In 1983, he moved to the Vanderbilt University School of Medicine as an Assistant Professor of Biochemistry and he has been on the faculty since that time. Dr. Osheroff currently holds Professorships in the Departments of Biochemistry and Medicine and was endowed with the John G. Coniglio Chair in Biochemistry in 2003. He has spent a combined 27 years on the editorial boards of The Journal of Biological Chemistry and Biochemistry and has authored over 240 publications. Dr. Osheroff's research focuses on topoisomerases, enzymes that remove knots and tangles from the genetic material and modulate torsional stress in DNA. In addition to their critical physiological roles, human type I and II topoisomerases are the targets for a number of widely used anticancer drugs. Furthermore, bacterial type II topoisomerases are the targets for quinolones, a drug class that includes some of the most frequently prescribed antibacterials in the world. The Osheroff laboratory has made seminal contributions to our understanding of how topoisomerases function and how anticancer drugs, natural products, and antibacterials interact with these enzymes and alter their catalytic functions. Beyond his research, Dr. Osheroff has a long-standing interest in mentoring and training young scientists and physicians. Twenty-seven Ph.D. students have graduated under his mentorship. Dr. Osheroff he has been a course director since 1990 and holds a number of educational leadership positions in the Vanderbilt University School of Medicine. Dr. Osheroff Chaired the NCI-I "Transition to Independence" study section from 2013-2016 and has held leadership positions in two international medical science educator organizations. Finally, Dr. Osheroff has received awards for mentoring, teaching, curricular design, educational service, and affirmative action and diversity. Over the past five years, he has been invited to present more than seventy scientific and educational talks at forty-six institutions/meetings in seventeen different countries.
              • Glenn Tillotson, SVP
                SVP Medical Affairs, CEMPRA Inc
                  Glenn is a Senior Vice President at Cempra Inc in Chapel Hill, USA. He is trained in medical microbiology and infectious diseases and almost 30 of pharmaceutical industry experience in various areas including clinical research, commercialization, scientific communications including publication planning, strategic drug development, life cycle management and global launch programs. Glenn has been instrumental in the development of ciprofloxacin and moxifloxacin as well as other drugs in the Bayer portfolio for whom he worked for 15 years. He later worked for Optimer Pharmaceuticals as Senior Vice President of Medical Affairs and built a team to support the launch of fidaxomicin (Dificid) the first new antibiotic for C difficile in over 20 years. Glenn is a member of the Scientific Steering Committee for the GTCBio Annual Summit on Anti-infective Partnering as well as the Anaerobe Society. He is also past Chair of the ACCP Chest Infection Network and a member of the ACCP Executive Council of Networks. In 2009 Glenn was honored by the American College of Chest Physicians with the Alfred Soffer Award for contributions to the College. Glenn is on several journal Editorial Advisory Boards including the Lancet Infectious Disease and F1000.
                Sponsored By

                For information on becoming a sponsor or exhibitor, please click here.


                To download the Program Committee brochure here.

                • Committee Chair: Tony Rook, MS

                  Tony A. Rook leads the Microbiology Resource Center at The Sherwin-Williams Company in Cleveland, OH, USA, where he has built a world-class Microbiology Center of Excellence to focus on global preservation strategies, continuous improvement of industrial hygiene practices, and ...

                  See more See less
                • Emily Hollister, PhD

                  Dr. Hollister is a microbial ecologist and bioinformaticist. She is interested in quantifying and characterizing microbial communities from a wide variety of environments, including the human body. Utilizing high throughput, next-generation DNA and RNA sequence approaches, her ...

                  See more See less
                • Marilyn Roossinck, PhD

                  Dr. Roossinck received a PhD in 1986 from the University of Colorado School of Medicine in Microbiology and Immunology, studying Hepatitis B virus, on an National Institutes of Health fellowship. Following a postdoctoral fellowship at Cornell University, where she began studying ...

                  See more See less
                • Glenn Tillotson, SVP

                  Glenn is a Senior Vice President at Cempra Inc in Chapel Hill, USA. He is trained in medical microbiology and infectious diseases and almost 30 of pharmaceutical industry experience in various areas including clinical research, commercialization, scientific communications ...

                  See more See less
                • Radhakrishna Tirumalai, PhD

                  Radhakrishna Tirumalai, PhD US Pharmacopeial Convention Dr. Tirumalai has been at the USP since 2003 and is currently a Principal Scientific Liaison in the Global Science and Standards Division. He is the Staff Liaison to the USP Expert Committees on Microbiology, and Toxicology ...

                  See more See less
                • Ivan Brukner, PhD

                • Philip Geis, PhD


                General LabRoots Questions

                For bugs, spam, technical support or questions please call +1-714-463-4673 or email  
                Contact us

                Virtual Events and Webinars

                Supported Configurations

                • Operating System Internet Explorer Firefox Chrome Safari
                  Vista IE8+ FF10+ Chrome15+
                  Windows 7 IE8+ FF10+ Chrome15+
                  Windows 8 IE10 FF10+ Chrome15+
                  Mac OS X   FF10+ Chrome15+ Safari5.1+
                • Cookie settings: session cookies enabled
                • Browser configuration must have JavaScript enabled
                • Adobe Flash player 10.2 or later

                To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                Internet Connection

                • A minimum of 100Kbps is recommended for audio-only events
                • A minimum of 300Kbps is recommended for speaker on-video events

                Computer Equipment

                • Screen Resolution: Minimum 1024x768
                • Video Card: 65,000 colors minimum
                • Sound card and speakers (or headphones) for hearing webcast in full format
                • Audio Card: 16-bit minimum
                • RAM: 512MB of free RAM

                Firewall Protocol

                • HTTP on port 80 or HTTPS on port 443
                • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                Work-At-Home Attendees

                • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                For A Seamless Experience

                When using a mobile device, FREE Mobile Apps are available:

                - For viewing Webinars:

                - For viewing Virtual Events

                Attendee Guide

                • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                Virtual Event and Webinar Support:

                Continuing Education (CME/CE) Support

                Loading Comments...
                Show Resources
                Event Countdown
                • 0 Days
                • 0 Hours
                • 0 Minutes
                • 0 Seconds